|
[1]DEJAGER L, PETTA I, BALLEGEER M, et al.The Interactome of the glucocorticoid receptor and its influence on the actions of glucocorticoids in combatting inflammatory and infectious diseases[J].Mol Biol Rev, 2016, 80 (2) :495-522.
|
|
[2]KHARB S, GARG MK, PURI P, et al.Assessment of adrenal function in liver diseases[J].Indian J Endocrinol Metab, 2013, 17 (3) :465-471.
|
|
[3]KRENKEL O, MOSSANEN JC, TACKE F.Immune mechanisms in acetamin-ophen-induced acute liver failure[J].Hepatobiliary Surg Nulr, 2014, 3 (6) :331043.
|
|
[4]NICOLAIDES NC, KYRATZI E, LAMPROKOSTOPOULOU A, et al.Stress, the stress system and the role of glucocorticoids[J].Neuroimmunomodulation, 2015, 22 (1-2) :6-19.
|
|
[5]MIYATA M, LEE JY, SUSUKI-MIYATA S, et al.Glucocorticoids supperess inflammation via the upregulationof negative regulator IRAK-M[J].Nat Commun, 2015, 6:6062.
|
|
[6]KIM EJ, LEE JG, KIM JY, et al.Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets[J].Immunology, 2017, 152 (4) :628-637.
|
|
[7]DEJAGER L, VANDEVYVER S, PETTA I, et al.Dominance of the strongest:Inflammatory cytokines Versus glucoconicoids[J].Cytokine Growth Factor Rev, 2014, 25 (1) :21-33.
|
|
[8]OAKLEY RH, CIDLOWSKI JA.The biology of the glucoconicoid receptor:New signaling mechanisms in health and disease[J].J Allergy Clin Immunol, 2013, 132 (5) :1033-1044.
|
|
[9]LINOSSI EM, BABON JJ, HILTON DJ, et al.Suppression of cytokine signaling:The SOCS perspective[J].Cytokine Growth Factor Rev, 2013, 24 (3) :241-248.
|
|
[10]PHILIP AM, VIJAYAN MM.Stress-immune-growth interactions:Cortisol modulates suppressors of cytokine signaling and JAK/STAT pathway in rainbow trout liver[J].PLo S One, 2015, 10 (6) :e0129299.
|
|
[11]KWON HJ, WON YS, PARK O, et al.Opposing effects of prednisolone treatment on T/NKT cell-and hepatotoxin-mediated hepatitis in mice[J].Hepatology, 2014, 59 (3) :1094-1106.
|
|
[12]CHEN JF, WANG KW, ZHANG SQ, et al.Dexamethasone in outcome of patients with hepatitis B virus-related acute-on-chronic liver failure[J].J Gastroenterol Hepatol, 2014, 29 (4) :800-806.
|
|
[13]ZHANG XQ, JIANG L, YOU JP, et al.Efficacy of short term dexamethasone therapy in acute-on-chronic pre-liver failure[J].Hepatol Res, 2011, 41 (1) :46-53.
|
|
[14] THURSZ MR, RICHARDSON P, ALLISON M, et al.Prednisolone or pentoxifylline for alcoholic hepatitis[J].N Engl J Med, 2015, 372 (17) :1619-1628.
|
|
[15]MENDIZABAL M, MARCIANO S, VIDELA MG, et al.Fulminant presentation of autoimmune hepatitis:Clinical features and early predictors of corticosteroid treatment failure[J].Eur J Gastroenterol Hepatol, 2015, 27 (6) :644-648.
|
|
[16]ZHAO B, ZHANG HY, XIE GJ, et al.Evaluation of the efficacy of steroid therapy on acute liver failure[J].Exp Ther Med, 2016, 12 (5) :3121-3129.
|
|
[17]SHASTHRY SM, SARIN SK.New treatment options for alcoholic hepatitis[J]World J Gastroenterol, 2016, 22 (15) :3892-3906.
|
|
[18] ZHU B, YOU SL, WAN ZH, et al.Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure[J].World J Gastroenterol, 2014, 20 (23) :7473-7479.
|
|
[19]BOCKMANN JH, DANDRI M, LUTH S, et al.Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure[J].World J Gastroenterol, 2015, 21 (7) :2214-2219.
|
|
[20]FUJIWARA K, YASUI S, YONEMITSU Y, et al.Efficacy of high-dose corticosteroid in the early stage of viral acute liver failure[J].Hepatol Res, 2014, 44 (5) :491-501.
|
|
[21]D'AGNOLO HM, DRENTH JP.High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis:A case report and brief review of literature[J].Neth J Med, 2013, 71 (4) :199-202.
|
|
[22]OLIVEIRA AT, LOPES S, CIPRIANO MA, et al.Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis[J].BMJ Case Rep, 2015, 2015:bcr2015210722.
|
|
[23]XUAN D, YU Y, SHAO L, et al.Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy—a report of long-term follow-up of serial cases and literature review[J].Clin Rheumatol, 2014, 33 (4) :577-586.
|
|
[24]HE B, ZHANG Y, LV MH, et al.Glucocorticoids can increase the survival rate of patients with severe viral hepatitis B:A meta-analysis[J].Eur J Gastroenterol Hepatol, 2013, 25 (8) :926-934.
|
|
[25]KOSKINAS JS, DEUTSCH M, ADAMIDI S, et al.The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients.A real life experience from a tertiary center[J].Eur J Intern Med, 2014, 25 (8) :768-771.
|
|
[26]YASUI S, FUJIWARA K, NAKAMURA M, et al.Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B[J].J Viral Hepat, 2015, 22 (2) :92-100.
|
|
[27]PARKER R, ARMSTRONG MJ, CORBETT C, et al.Systematic review:pentoxifylline for the treatment of severe alcoholic hepatitis[J].Aliment Pharmacol Ther, 2013, 37 (9) :845-854.
|
|
[28] THURSZ MR, RICHARDSON P, ALLISON M, et al.Prednisolone or pentoxifylline for alcoholic hepatitis[J].N Engl J Med, 2015, 372 (17) :1619-1628.
|
|
[29]FACCIORUSSO A, CHANDAR AK, MURAD MH, et al.Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome:A systematic review and network meta-analysis[J].Lancet Gastroenterol Hepatol, 2017, 2 (2) :94-102.
|
|
[30]European Association for the Study of Liver.EASL clinical practical guidelines:Management of alcoholic liver disease[J].J Hepatol, 2012, 57 (2) :399-420.
|
|
[31]GARCIA-SAENZ-de-SICILIA M, DUVOOR C, ALTAMIRANO J, et al.A day-4 lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis[J].Am J Gastroenterol, 2017, 112 (2) :306-315.
|
|
[32]GUSTOT T, MAILLART E, BOCCI M, et al.Invasive aspergillosis in patients with severe alcoholic hepatitis[J].J Hepatol, 2014, 60 (2) :267-274.
|
|
[33]CZAJA AJ.Diagnosis and management of autoimmune hepatitis[J].Clin Liver Dis, 2015, 19 (1) :57-79.
|
|
[34]ZHU B, YOU SL, WAN ZH, et al.Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure[J].World J Gastroenterol, 2014, 20 (23) :7473-7379.
|
|
[35]YEOMAN AD, WESTBROOK RH, ZEN Y, et al.Prognosis of acute severe autoimmune hepatitis (AS-AIH) :The role of eortieosteroids in modifying outcome[J].J Hepatol, 2014, 61 (4) :876-882.
|
|
[36]FISHER K, VUPPALANCHI R, SAXENA R.Drug-induced liver injury[J].Arch Pathol Lab Med, 2015, 139 (7) :876-887.
|
|
[37]CHEN M, SUZUKI A, BORLAK J, et al.Drug-induced liver injury:Interactions between drug properties and host factors[J].Hepatol, 2015, 63 (2) :503-514.
|
|
[38]KUMAGAI J, KANDA T, YASUI S, et al.Autoimmune hepatitis following drug-induced liver injury in an elderly patient[J].Clin J Gastroenterol, 2016, 9 (3) :156-159.
|
|
[39]HU PF, WANG PQ, CHEN H, et al.Beneficial effect of corticosteroids for patients with severe drug-induced liver injury[J].Dig Dis, 2016, 17 (9) :618-627.
|
|
[40]KARKHANIS J, VERNA EC, CHANG MS, et al.Steroid use in acute liver failure[J].Hepatology, 2014, 59 (2) :612-621.
|
|
[41]THURSE MR, RICHARDSON P, ALLISON M, et al.Prednisolone or pentoxifylline for alcoholic hepatitis[J].N Engl J Med, 2015, 372 (17) :1619-1628.
|
|
[42]LEE YS, KIM HJ, KIM JH, et al.Treatment of severe alcoholic hepatitis with corticosteroid, pentoxifylline, or dual therapy:A systematic review and meta-analysis[J].J Clin Gastroenterol, 2017, 51 (4) :364-377.
|
|
[43]YASUI S, FUJIWARA K, HAGA Y, et al.Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure:Analysis in a Japanese center[J].J Hepatobiliary Pancreat Sci, 2016, 23 (12) :756-762.
|
DownLoad: